Workflow
Petco Health and Wellness pany(WOOF) - 2026 Q1 - Quarterly Report

Financial Performance - Net sales decreased from 1.53billionto1.53 billion to 1.49 billion, representing a period-over-period decrease of 2.3%[82] - Operating income improved to 16.4million,comparedtoanoperatinglossof16.4 million, compared to an operating loss of 16.8 million in the prior year period[82] - Net loss attributable to Class A and B-1 common stockholders decreased from 46.5millionto46.5 million to 11.7 million[82] - Adjusted EBITDA increased from 75.6millionto75.6 million to 89.4 million[82] - Comparable sales change was a decline of 1.3% for the thirteen weeks ended May 3, 2025[84] - Adjusted EBITDA for the thirteen weeks ended May 3, 2025, was 89.4million,comparedto89.4 million, compared to 75.6 million for the same period in 2024, representing a 18.2% increase[96] - Net sales for the thirteen weeks ended May 3, 2025, were 1.49billion,adecreasefrom1.49 billion, a decrease from 1.53 billion in the same period in 2024, reflecting a 2.5% decline[96] - Adjusted EBITDA Margin improved to 6.0% for the thirteen weeks ended May 3, 2025, compared to 4.9% in the same period in 2024[96] Cost and Expenses - Gross profit margin improved to 38.2% from 37.8% year-over-year[87] - SG&A expenses as a percentage of net sales decreased from 38.9% to 37.1%[88] - Interest expense decreased by 3.3million,or9.03.3 million, or 9.0%, to 33.5 million[89] Cash Flow and Liquidity - Free Cash Flow for the thirteen weeks ended May 3, 2025, was (43.9)million,comparedto(43.9) million, compared to (41.1) million for the same period in 2024, indicating a slight increase in cash outflow[100] - As of May 3, 2025, the company's liquidity was 647.9million,including647.9 million, including 133.3 million in cash and cash equivalents and 514.6millionavailableontheABLRevolvingCreditFacility[102]Netcashusedinoperatingactivitieswas514.6 million available on the ABL Revolving Credit Facility[102] - Net cash used in operating activities was (15.5) million for the thirteen weeks ended May 3, 2025, compared to (8.4)millionforthesameperiodin2024,primarilyduetolowersalesandhigherincentivebonuses[106]Cashusedininvestingactivitiesdecreasedto(8.4) million for the same period in 2024, primarily due to lower sales and higher incentive bonuses[106] - Cash used in investing activities decreased to 27.1 million for the thirteen weeks ended May 3, 2025, from 31.7millioninthesameperiodin2024,drivenbyfewernewpetcarecentersandhospitals[107]Netcashusedinfinancingactivitieswas31.7 million in the same period in 2024, driven by fewer new pet care centers and hospitals[107] - Net cash used in financing activities was (0.3) million for the thirteen weeks ended May 3, 2025, a decrease from (5.6)millioninthesameperiodin2024,duetolowertaxwithholdingpayments[108]DebtandCreditFacilitiesTheFirstLienTermLoanoutstandingasofMay3,2025,was(5.6) million in the same period in 2024, due to lower tax withholding payments[108] Debt and Credit Facilities - The First Lien Term Loan outstanding as of May 3, 2025, was 1.60 billion, with variable interest rates that could increase annual cash interest by approximately 16.2millionifratesriseby100basispoints[118]Thecompanyhasasecuredassetbasedrevolvingcreditfacilitywithavailabilityofupto16.2 million if rates rise by 100 basis points[118] - The company has a secured asset-based revolving credit facility with availability of up to 581.0 million, maturing in 2029, to support its liquidity needs[109] Business Operations - Total pet care centers in the U.S. and Puerto Rico decreased from 1,423 to 1,393[84] - The company continues to experience momentum in services, driven by strategic investments in customer acquisition and retention[85]